?:authorAffiliation
|
-
[\'Reference Center for Rare Pulmonary Diseases, Pulmonary Medicine and Intensive Care Unit Department, Dijon University Hospital, BP 77908, 21079, Dijon, France.\', \'CHU de Dijon - Service de Biostatistique et d\'Informatique Médicale, BP 77908, 21079, Dijon CEDEX, France.\', \'University of Burgundy and Franche-Comté, Dijon, France.\', \'Université Paris-Saclay, UVSQ, Univ. Paris-Sud, Inserm, High-Dimensional Biostatistics for Drug Safety and Genomics, CESP, Villejuif, France.\', \'Clinical Investigation Center, Clinical Epidemiology/Clinical Trials Unit, Inserm, CIC 1432, Dijon, France ; Dijon University Hospital, Dijon, France.\', \'Chest Department and Constitutive Center for Rare Pulmonary Disease, Hôpital Tenon, AP-HP, Inflammation-Immunopathology-Biotherapy Department (DHU i2B) and Sorbonne Université, 75020, Paris, France.\', \'Faculty of Medicine, University of Burgundy and Franche-Comté, Dijon, France.\', \'Infectious Diseases Department, Dijon University Hospital, BP 77908, 21079, Dijon, France.\', \'INSERM, LNC UMR1231, LipSTIC LabEx Team, Dijon, France.\', \'CHU de Dijon - Service de Biostatistique et d\'Informatique Médicale, BP 77908, 21079, Dijon CEDEX, France. catherine.quantin@chu-dijon.fr.\', \'University of Burgundy and Franche-Comté, Dijon, France. catherine.quantin@chu-dijon.fr.\', \'Université Paris-Saclay, UVSQ, Univ. Paris-Sud, Inserm, High-Dimensional Biostatistics for Drug Safety and Genomics, CESP, Villejuif, France. catherine.quantin@chu-dijon.fr.\', \'Clinical Investigation Center, Clinical Epidemiology/Clinical Trials Unit, Inserm, CIC 1432, Dijon, France ; Dijon University Hospital, Dijon, France. catherine.quantin@chu-dijon.fr.\']
|